What We're Reading: Page 282
Industry reads hand-picked by our editors
Nov 10, 2017
Nov 09, 2017
-
The New York Times
Gene therapy creates replacement skin to save a dying boy
-
Bloomberg
Trump expected to name ex-Lilly executive Azar HHS Secretary
-
MarketWatch
Republican bill would get rid of tax credits for rare disease drugs
-
Financial Times
GlaxoSmithKline appoints Hal Barron as R&D chief
Nov 08, 2017
-
Pharmaceutical Executive
Taiwan’s biotech boom
-
Phys.org
Targeting a single protein might treat a broad range of viruses
-
Politico
GOP senators say they'll oppose defense bill if Pentagon drug policy stays in
-
Sports Illustrated
Can a drug treat concussions? Brett Favre is betting on it
Nov 07, 2017
-
San Francisco Chronicle
Biotech faces up to its own leadership diversity problem
-
Bloomberg
Teva’s credit rating cut to junk by fitch
-
The Washington Post
CVS adds next-day prescription delivery as threat of Amazon competition looms
Nov 06, 2017
Nov 03, 2017
-
Bloomberg
This biotech scientist says Washington needs to remember the basics
-
Los Angeles Times
CVS and Aetna eye competition from Amazon, but the real race is with UnitedHealth
-
Triangle Business Journal
Cash Crunch: Local life science companies struggle to raise capital
-
Scientific American
MDMA's journey from Molly to medicine
Nov 02, 2017
-
The Atlantic
How trust shapes nations' safety rules
-
Boston Business Journal
A requirement at this Cambridge biotech: Must love dogs
-
Kaiser Health News
Timeline: insulin market under scrutiny
Previous
